Cure My Disease

Don't miss your cure!

 Log in / Sign up

Two nerve block techniques face off against standard infiltration in the push for Opioid-Free breast surgery

NCT ID NCT07811323

Symptom relief Sponsor: Gaziantep City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 10, 2026 · Last updated Sep 15, 2026 · Updated 3 times

Summary

Breast reduction surgery causes significant early pain, and doctors want to know which regional pain technique works best. This study compares two ultrasound-guided nerve blocks, PECS II and serratus anterior plane, against standard tumescent local anesthetic infiltration in 60 patients aged 18 to 70. Researchers track opioid consumption, pain scores, and recovery quality in the first 24 hours to see which approach minimizes painkiller needs and supports faster recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ultrasound-guided nerve blocks (PECS II and serratus anterior plane) versus tumescent local anesthetic infiltration
What this could lead to
If one approach works better, it could shape pain protocols that cut opioid use and speed recovery after breast reduction surgery.
What could go wrong
This is a small observational study of 60 patients at a single center, so results may not apply broadly. Nerve blocks carry small risks of bleeding, infection, or nerve irritation, and individual pain experiences vary widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2027

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients scheduled for elective oncoplastic or reconstructive reduction mammoplasty surgery. * Patients aged between 18 and 70 years.American Society of Anesthesiologists (ASA) physical status classification I, II, or III. * Patients who voluntarily agree to participate and sign the informed consent form. Exclusion Criteria: * Patient refusal to participate in the study or to receive regional anesthesia. * Active localized infection at the site of the proposed block or surgical area. * Coagulopathy, bleeding disorders, or patients on active anticoagulant therapy. * Psychiatric or cognitive disorders that prevent the understanding of the NRS or QoR-15 scoring systems. * History of revision breast surgery or emergency procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Analgesia obtained with A local wound infiltration of lidocain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Analgesia obtained with A local wound infiltration of lidocain Breast surgery Mammaplasty

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Gaziantep City Hospital

    Gaziantep, şahinbey, 27072, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.